Norway· NO-ID_6F0FDBAE-125D-40C6-87CF-E8A99379716F
Proxymetacaine Minims
A proxymetacaine product containing proksymetakain, registered in Norway by Bausch & Lomb (England). The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Proxymetacaine is registered in 10 of 19 countries.
Countries holding a registration under ATC S01HA04 (proxymetacaine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Proxymetacaine · ATC S01HA04
10 / 19 countries
- Belgiumprice
- Canada
- Germany
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Proksymetakain
- Manufacturer
- Bausch & Lomb (England)
- Country
- Norway (NO)
- ATC code
- S01HA04
- ATC class
- Proxymetacaine
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_6F0FDBAE-125D-40C6-87CF-E8A99379716F
- no_varenummer36191820 x 0.5
- gtin5397264009999
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for proxymetacaine.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Proxymetacaine · interactions on record
20 records
- 20 moderate
Most severe, free to view
- MetoclopramideA03FA01moderate
- SulfamethizoleB05CA04moderate
- LidocaineC01BB01moderate
- Silver sulfadiazineD06BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Proxymetacaine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAlcaineAlcon Laboratories, Inc.
- PolandAlcaineDelfarma Sp. z o.o.
- SwitzerlandAlcaine, AugentropfenAlcon Switzerland SA
- GermanyProparakain-PosUrsapharm Arzneimittel Gmbh
- United KingdomMinims proxymetacaine 0.5% eye drops 0.5ml unit doseBausch & Lomb UK Ltd
- BelgiumAlcaine 0.5 %Alcon
- IcelandAlcaineAlcon Nordic A/S
- IrelandMinims Proxymetacaine hydrochloride 0.5% w/v, Eye Drops, SolutionBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Alcaine
- Bulgaria · Алкаин
- Cyprus · Alcaine
- Germany · Proparakain-Pos
- United Kingdom (Northern Ireland) · Proxymetacaine Hydrochloride Minims Bausch & Lomb Uk
- Greece · Alcaine
- Ireland · Minims
- Iceland · Alcaine
- Lithuania · Alcaine
- Poland · Alcaine
- Slovenia · Alcaine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af6490bf-df40-4ce6-84fa-7ff092b944b5 GET /v1/drugs/af6490bf-df40-4ce6-84fa-7ff092b944b5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Proksymetakain",
"merkevare_id": "ID_6F0FDBAE-125D-40C6-87CF-E8A99379716F",
"name_form_strength": "Proxymetacaine Minims øyedr, oppl 0,5 % w/v",
"prescription_group": "C"
}See everything about proxymetacaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.